Biotech 2050 Podcast
101. Revolutionizing genetic medicine, Paula Soteropoulos, Chairman of the Board, Ensoma
over 2 years ago
100. Disruptive forces in biotech, Jake Becraft, Lex Rovner, Josh Mandel-Brehm, & Nabiha Saklayen
over 2 years ago
99. Precision medicine for sepsis, Tim Sweeney, Co-Founder and CEO, Inflammatix, Inc.
over 2 years ago
97. Patient driven treatments in rare diseases, Stuart Peltz, Founder & CEO, PTC Therapeutics
over 3 years ago
96. Obesity & rare disease, Patrick Kleyn, SVP and Head of Translational R&D,Rhythm Pharmaceuticals
over 3 years ago
95. Gene writing, Dr. Jake Rubens, Co-Founder & CIO, Hari Pujar, COO, Tessera Therapeutics
over 3 years ago
94. Cell therapy in a war on cancer, Kleanthis Xanthopoulos, Co-Founder & CEO, Shoreline Biosciences
over 3 years ago